Insider Trading Alert - AWAY, LCI And HTGC Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Dec. 3, 2014, 112 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $402.00 to $128,403,039.00.

Highlighted Stocks Traded by Insiders:

HomeAway (AWAY) - FREE Research Report

Hale Thomas E, who is Chief Product Officer at HomeAway, sold 361 shares at $31.14 on Dec. 3, 2014. Following this transaction, the Chief Product Officer owned 89,150 shares meaning that the stake was reduced by 0.4% with the 361-share transaction.

Bellm Brent, who is President & COO at HomeAway, sold 1,167 shares at $30.87 on Dec. 3, 2014. Following this transaction, the President & COO owned 91,390 shares meaning that the stake was reduced by 1.26% with the 1,167-share transaction.

The shares most recently traded at $31.88, up $1.01, or 3.18% since the insider transaction. Historical insider transactions for HomeAway go as follows:

  • 4-Week # shares sold: 894
  • 12-Week # shares sold: 894
  • 24-Week # shares sold: 5,802

The average volume for HomeAway has been 1.3 million shares per day over the past 30 days. HomeAway has a market cap of $3.0 billion and is part of the technology sector and internet industry. Shares are down 22.36% year-to-date as of the close of trading on Tuesday.

HomeAway, Inc., together with its subsidiaries, operates an online vacation rental property marketplace that enables property owners and managers to market properties for rental to vacation travelers. The company has a P/E ratio of 264.5. Currently, there are 10 analysts who rate HomeAway a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on AWAY - FREE

TheStreet Quant Ratings rates HomeAway as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, deteriorating net income and disappointing return on equity. Get the full HomeAway Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Lannett (LCI) - FREE Research Report

Maher James M., who is Director at Lannett, bought 500 shares at $46.53 on Dec. 3, 2014. Following this transaction, the Director owned 11,500 shares meaning that the stake was boosted by 4.55% with the 500-share transaction.

The shares most recently traded at $48.09, up $1.56, or 3.24% since the insider transaction. Historical insider transactions for Lannett go as follows:

  • 4-Week # shares bought: 500
  • 4-Week # shares sold: 17,500
  • 12-Week # shares bought: 500
  • 12-Week # shares sold: 55,000
  • 24-Week # shares bought: 500
  • 24-Week # shares sold: 82,500

The average volume for Lannett has been 798,500 shares per day over the past 30 days. Lannett has a market cap of $1.7 billion and is part of the health care sector and drugs industry. Shares are up 41.21% year-to-date as of the close of trading on Tuesday.

Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of branded pharmaceutical products in the United States. It offers solid oral, extended release, topical, and oral solution finished dosage forms of drugs that address a range of therapeutic areas. The company has a P/E ratio of 16.8. Currently, there are 3 analysts who rate Lannett a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on LCI - FREE

TheStreet Quant Ratings rates Lannett as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, attractive valuation levels and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Lannett Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Hercules Technology Growth Capital (HTGC) - FREE Research Report

Shah Parag, who is Senior Managing Director at Hercules Technology Growth Capital, sold 22,500 shares at $15.33 on Dec. 3, 2014. Following this transaction, the Senior Managing Director owned 251,834 shares meaning that the stake was reduced by 8.2% with the 22,500-share transaction.

The shares most recently traded at $15.12, down $0.21, or 1.39% since the insider transaction. Historical insider transactions for Hercules Technology Growth Capital go as follows:

  • 4-Week # shares sold: 24,500
  • 12-Week # shares bought: 3,127
  • 12-Week # shares sold: 113,000
  • 24-Week # shares bought: 3,127
  • 24-Week # shares sold: 286,000

The average volume for Hercules Technology Growth Capital has been 337,800 shares per day over the past 30 days. Hercules Technology Growth Capital has a market cap of $982.9 million and is part of the financial sector and real estate industry. Shares are down 6.1% year-to-date as of the close of trading on Tuesday.

Hercules Technology Growth Capital, Inc. The stock currently has a dividend yield of 8.1%. The company has a P/E ratio of 13.0. Currently, there are 4 analysts who rate Hercules Technology Growth Capital a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HTGC - FREE

TheStreet Quant Ratings rates Hercules Technology Growth Capital as a buy. Among the primary strengths of the company is its expanding profit margins over time. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Hercules Technology Growth Capital Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Global Stocks Rise on Tech Resurgence; Dollar Past 3-Month High Ahead of Q1 GDP

Global Stocks Rise on Tech Resurgence; Dollar Past 3-Month High Ahead of Q1 GDP

AMD Rises Above the Competition; Loan Losses Mount for Big Banks -- ICYMI

AMD Rises Above the Competition; Loan Losses Mount for Big Banks -- ICYMI

McKesson Internal Review Clears Senior Management of Wrongdoing on Opioids

McKesson Internal Review Clears Senior Management of Wrongdoing on Opioids

Starbucks Surprises Wall Street With U.S. Sales Up a Paltry 2%

Starbucks Surprises Wall Street With U.S. Sales Up a Paltry 2%

Dow Jumps 238 Points as S&P 500, Nasdaq Also Climb

Dow Jumps 238 Points as S&P 500, Nasdaq Also Climb